Contrast Induced Nephropathy (CIN) Terminated Phase 1 Trials for Acetylcysteine (DB06151)
Also known as: Contrast Induced Nephropathy
| Indication | Status | Phase |
|---|---|---|
| DBCOND0066353 (Contrast Induced Nephropathy (CIN)) | Terminated | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00575419 | Safety Study Of N-Acetylcysteine For Prevention Of Contrast Induced Nephropathy In Patients w/Stage 3 Renal Failure | Prevention |